CYP19A1 and obesity disorder: The ER+BC promoting action of obesity, mainly in postmenopausal women, has been attributed to increase in circulating [87] and adipose tissue levels of estrogen, as a result of upregulation of aromatase enzyme in fat depots of obese patients [13,16,18,30,41,42].